Enacted: Aug 30, 2007
First revision: May 25, 2009
Second revision: Feb 8, 2013
Third revision: Dec 30, 2021
Fourth revision: Feb 18, 2022
GENERAL INFORMATION
Annals of Clinical Nutrition and Metabolism (ACNM), the
official scientific journal of the Korean Society of Surgical
Metabolism and Nutrition (KSSMN) and Korean Society for
Parenteral and Enteral Nutrition (KSPEN), is an international,
peer-reviewed open access journal published half-yearly
in June 1, December 1, with the purpose of publishing
research and therapeutic achievements in the field of Clinical
nutrition and metabolism. ACNM publishes 1) original
articles, 2) case reports, 3) review articles, 4) editorials, and
5) letters to the editors. All manuscripts for ACNM must be
submitted through the on-line Submission System website
(http://e-acnm.org/). Authors have to log into their account in the on-line system, which will lead the authors through
the submission process.
For the policies on research and publication ethics, follow
the policies established by the ‘Good Publication Practice
Guidelines for Medical Journals’(https://www.kamje.or.kr/
board/view?b_name=bo_publication&bo_id
=13&per_page=)
or the ‘Ethical Guidelines on Good Publication’ (http://publicationethics.
org/resources/
guidelines) or Ethical Considerations
in ICMJE (http://www.icmje.org/index.html), especially
those on the disclosure of conflicts of interest, statement of
informed consent, statement of human and animal rights,
Institutional Review Board (IRB), authorship, originality,
duplicate publication, and clinical trials registry. Any attempt
to duplicate publication or any plagiarism will lead to
automatic rejection, may prejudice the acceptance of future
submissions, and may be highlighted within the pages of the
journal.
RESEARCH POLICY
Protection of human and animal right
While reporting experiments that involve human subjects, it
should be stated that the study was performed according to
the Helsinki Declaration (https://www.wma.net/policies-post/
wma-declaration-of-helsinki-ethical-principles-for-medicalresearch-
involving-human-subjects/) and approved by the
IRB of the institution where the experiment was performed.
A written informed consent should be obtained from all subjects.
In the case of an animal study, a statement should be
provided indicating that the experiment process, such as the
breeding and the use of laboratory animals, was approved
by the REC of the institution where the experiment was performed
or that it does not violate the rules of the REC of the
institution or the NIH Guide for the Care and Use of Laboratory
Animals (Institute of Laboratory Animal Resources,
Commission on Life Sciences, National Research Council,
http://www.nap.edu/readingroom/books/labrats/index.html).
The authors should preserve raw experimental study data for
at least 1 year after the publication of the paper and should
present this data if required by the editorial board.
Conflicts of interest
A conflict of interest exists when an author (or the author’s
institution), reviewer, or editor has financial or personal relationships
that inappropriately influence (bias) their actions
(such relationships are also known as dual commitments,
competing interests, or competing loyalties). All authors
should disclose their conflicts of interest, i.e., (1) financial
relationships (such as employment, consultancies, stock
ownership, honoraria, paid expert testimony), (2) personal
relationship, (3) academic competition, and (4) intellectual
passion. The conflicts of interest may occur during the research
process; however, the important point is the disclosure
itself. Disclosure allows the editors, reviewers, and readers to
approach the manuscript with an understanding of the situation
under which the research work was processed (http://
www.icmje.org/conflicts-of-interest/). Even when there is no
conflict of interest, it should also be stated. When the manuscript
is accepted for publication, ACNM will decide whether
the disclosure will be communicated in the published paper
(after consulting with the corresponding author).
Personal information protection
The rights of patients should not be infringed without written
informed consent. Identifying details should not be published
in written descriptions, photographs, and pedigrees
unless it is essential for scientific purposes and the patient
(or his/her parents or guardian) provides written informed
consent for publication. However, complete patient anonymity
is difficult to achieve; therefore, informed consent should
be obtained in the event that anonymity of the patient is
not assured. For example, masking the eye region of patients
in photographs is not adequate to ensure anonymity. If
identifying characteristics are changed to protect anonymity,
authors should provide assurance that alterations do not
distort scientific meaning and editors should take note of
this. When informed consent has been obtained, it should
be indicated in the published article. The ICMJE has recommended
the following statement for the protection of privacy,
confidentiality, and written informed consent.
Fabrication, falsification, plagiarism
Redundant publication is defined as “reporting (publishing
or attempting to publish) substantially the same work more
than once, without attribution of the original source(s)."
Characteristics of reports that are substantially similar include
the following: 1) “at least one of the authors must be
common to all reports (if there are no common authors, it is
more likely plagiarism than redundant publication)," 2) “the
subjects or study populations are the same or overlapped," 3)
“the methodology is typically identical or nearly so," and 4)
“the results and their interpretation generally vary little, if at
all." When submitting a manuscript, authors should include
a letter informing the editor of any potential overlap with
other already published material or material being evaluated
for publication and should also state how the manuscript
submitted to ACNM differs substantially from other materials.
If all or part of your patient population was previously
reported, this should be mentioned in the Materials and
methods, with citation of the appropriate reference(s).
PUBLICATION POLICY
Authorship
Authorship credit must be based on the ICMJE (http://www.
icmje.org/icmje-recommendations.pdf). An author is considered
as an individual who has made substantive intellectual
contributions to a published study and whose authorship
continues to have important academic, social, and financial
implications. Authors are responsible for the whole content
of each article. Co-authorship should be based on the following
4 criteria: (1) substantial contributions to the conception
or designing of the work; or the acquisition, analysis,
or interpretation of data for the work; (2) drafting or revising
of the work critically for important intellectual content; (3)
final approval of the version to be published; and (4) agreement
to be accountable for all aspects of the work in ensuring
that questions related to the accuracy or integrity of any
part of the work are appropriately investigated and resolved.
Participation solely in the acquisition of funding or the collection
of data does not justify authorship and, except in
the case of complex large-scale or multi-centre research, the
number of authors should usually not exceed six. Any persons
who do not meet the 4 criteria above should be placed
as contributors in Acknowledgments section.
Policies on research and publication ethics that are not
stated in the Instructions can be found in the Guidelines on
Good Publication (https://publicationethics.org/guidance/
Guidelines) or Good Publication Practice Guidelines for Medical
Journals (https://www.kamje.or.kr/en/main_en ).
Duplicate publication
Manuscripts are only accepted for publication in journals if
they have not been published elsewhere. Manuscripts published
in this journal should not be submitted for publication
elsewhere. If the author(s) wishes to obtain a duplicate
or secondary publication for various other reasons, such as
for readers of a different language, he/she should obtain
approval from the editors-in-chief of both the first and
second journal. It is mandatory that all authors resolve any
copyright issues when citing a figure or table from a different
journal that is not open-access. Regarding duplicate
publication, plagiarism, and other problems related to publication
ethics, the ‘Good Publication Practice Guidelines for
Medical Journals' (https://www.kamje.or.kr/board/view?b_
name=bo_publication&bo_id=13&per_page=) should be
followed.
COPYRIGHT
Copyrights ownership is to be transferred to the ACNM. If
the journal retains copyright, it should detail the journal’s
position on the transfer of copyright for all types of content,
including audio, video, protocols, and data sets. This is an
open access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/4.0), which permits unrestricted
use, distribution, and reproduction in any medium,
provided the original work is properly cited.
MANUSCRIPT PREPARATION
General principles
1. Languages
Manuscripts should be written in English. Medical terminology
should conform to the most recent edition of Dorland’s
Illustrated Medical Dictionary.
2. Word processors and format of manuscript
Manuscripts must be submitted as MS-WORD (2003 or higher)
files using a normal, plain format in grammatically correct
English. Manuscripts must be typed in English, doublespaced
and 11 point type, and all pages must be numbered
consecutively. Each section should begin on a separate sheet
and follow in that order. The title page should be separated
from the main text manuscript file.
3. Abbreviation of terminology
Abbreviations should be avoided as much as possible. One
word should not be expressed through an abbreviation, although
more than two words may be expressed through an
abbreviation. The full term for which the abbreviation stands
should be used at its first occurrence in the text. Abbreviations
should not be present in the title. Common abbreviations,
however, may be used, such as DNA.
4. Units
The use of International Standardized (SI) units is encouraged.
These are available at https://physics.nist.gov/cuu/
Units/index.html or https://physics.nist.gov/cuu/pdf/sp811.
pdf. Arabic numbers should be used, and all units use SI unit
(International Systemic of Units). Use a comma after thousands
(ex. 10,000).
5. Machine and equipment
When the use of reagents or devices is reported in the text,
the name of the manufacturer, city, state, and country
should be indicated. Regarding devices, reagents, and medicine,
information on manufacturing company, city, and nation
should be provided in parenthesis.
6. Statistics
Statistical methods must be described and the program used
for data analysis, and its source, should be stated.
Original articles
The manuscripts for original articles should be organized in
the following order: Title page, Abstract, Main text, Author
contributions, Conflicts of interest, Acknowledgments, Funding,
References, Tables, Figure legends, and Figures.
1. Title page
Title page is comprised of the title of the article, full name
of each author and authors’ affiliations. For authors with
different affiliations, the authors should be marked “1," “2,"
“3," and so forth in Arabic numerals, which should appear
in superscript at the top-right-hand corner of the author’s
name and before the affiliation. Also include the name, email,
and ORCID ID of the corresponding author, and the
place and date of any scientific meetings where the material
may have been presented. All sources of financial and material
support should be presented at the bottom of the title
page. ACNM requests to include all authors’ ORCID ID in the
title page. To obtain an ORCID, authors should register at
the ORCID website: https://orcid.org. Registration is free for
all researchers.
2. Abstract
All manuscripts should contain a structured abstract. Abstracts
should be no more than 250 words in length and
must have the following headings: Purpose, Materials and
Methods, Results, Conclusion. The quotation of references
must not be included in the abstract. A maximum of 5 keywords
should be listed, immediately after the abstract, in
alphabetical order. These words should be drawn from the
Medical Subject Heading (MeSH) terminology in the United
States National Library of Medicine’s (NLM) MEDLINE database
(https://meshb.nlm.nih.gov/search). The first letter of
the keyword should be capitalized and the remaining letters
should be lower case; they should be separated by a semicolon,
without a period at the end of the last word.
3. Main text
The main text of the original article should include Introduction,
Materials and methods, Results, Discussion, and Conclusion
sections.
1) Introduction should provide a brief background and aims
of the study.
2) Materials and methods should clearly provide your selection
of the observational or experimental participants,
including eligibility and exclusion criteria and a description
of the source population in the case of clinical research. In
addition, give statistical methods and provide references and
brief descriptions for methods that have been published.
Give reasons for using new or modified methods. Methods
of clinical trial should be presented with the approval of the
Institutional Review Board (IRB) and informed consents from
patients enrolled in that trial. Ensure correct use of the terms
sex (when reporting biological factors) and gender (identity,
psychosocial or cultural factors), and, unless inappropriate,
report the sex and/or gender of study participants, the sex of
animals or cells, and describe the methods used to determine
sex and gender. If the study was done involving an exclusive
population, for example in only one sex, authors should
justify why, except in obvious cases (e.g., prostate cancer).
Authors should define how they determined race or ethnicity
and justify their relevance.
3) Results are listed according to the order of figures and
tables presenting the results of study. Do not repeat all data
in the figures or tables in the text of the results section and
emphasize the important results briefly.
4) Discussion should be limited to important aspects of the
study that follow from them. Do not repeat in detail data
or previously given information in the Results section. Avoid
content unrelated to the results.
5) Conclusion should be presented in a clear and concise
manner and help the reader understand why your research
should matter to them after they have finished reading the
paper. A conclusion is not merely a summary of your points
or re-statement of your research problem but a synthesis of
key points.
4. Acknowledgments
Persons or institutes that contributed to the papers but
whose contribution was not significant enough to be coauthors
may be introduced following Conclusion.
5. Author contributions
The journal uses the CRediT taxonomy to define author contributions.
Each author on a paper may have one or more
CRediT contribution roles. CRediT author contribution statements
should be provided during the submission. For more
details on CRediT, see https://casrai.org/credit/.
Conceptualization: OOO, OOO. Data curation: OOO, OOO.
Formal analysis: OOO, OOO. Funding acquisition: OOO,
OOO. Investigation: OOO, OOO. Methodology: OOO, OOO.
Project administration: OOO, OOO. Resources: OOO, OOO.
Software: OOO, OOO. Supervision: OOO, OOO. Validation:
OOO, OOO. Visualization: OOO, OOO. Writing – original
draft: OOO, OOO. Writing – review & editing: OOO, OOO.
(OOO: initial of author)
6. Conflict of interest
If there are any conflicts of interest, authors should disclose
them in the manuscript following the Acknowledgments
section. Disclosures allow editors, reviewers, and readers to
approach the manuscript with an understanding of the situation
and background of the completed research. Please
ACNM ANNALS OF CLINICAL NUTRITION AND METABOLISM
consult the COPE guidelines (http://www.publicationethics.
org/) on conflict of interest. If there are no conflicts of interest,
authors should include following sentence: “The authors
of this manuscript have no conflicts of interest to disclose."
7. Funding
Funding for the research should be provided here. Providing
a FundRef ID is suggested, including the name of the funding
agency, the country, and if available, the number of the
grant provided by the funding agency. If the funding agency
does not have a FundRef ID, please ask the agency to contact
the FundRef registry (e-mail: fundref.registry@crossref.
org). A detailed description of the FundRef policy can be
found at http://www.crossref.org/fundref/.
8. ORCID
All authors are required to provide his/her “Open Researcher
and Contributor ID (ORCID)", when submitting a manuscript to
ACNM. During the submission process, authors will have the option
to either create an ORCID ID or associate an existing ORCID
ID to their account. To learn more about ORCID, please visit
https://orcid.org/about.
9. References
References should be numbered consecutively in the order
in which they are first mentioned in the text. References
should be identified in text with full-size Arabic numerals
on the line and in square brackets [ ]. Up to six authors may
be listed. References with seven or more authors should list
only the first six followed by “et al." Names should be separated
by a comma and one space. References should follow
the rules of the International Committee of Medical Journal
Editors: Uniform requirements for manuscripts submitted to
biomedical journals. Journal titles that are not listed in the
Catalog should follow the ISO abbreviation as described in
“ISO 4:1997 Information and documentation--Rules for the
abbreviation of title words and titles of publications" (http://
www.iso.org/iso/home/store/catalogue_tc/catalogue_detail.
htm?csnumber=3569).
Journal
Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE.
Longterm results of infusional 5-FU, mitomycin-C, and
radiation as primary management of esophageal cancer.
Int J Radiat Oncol Biol Phys 1991;20:29-36.
Book
DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer:
Principles and Practice of Oncology. Vol 2. 4th ed. Philadelphia:
Lippincott, 1998.
Chapter in book
Ginberg RJ, Kris MG, Armstrong JG. Cancer of the lung.
In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer:
principles and practice of oncology. Vol 2. 4th ed. Philadelphia:
Lippincott, 1993:673-758.
Electronic format
Lee OJ, Cho YH, Hwang J, Yoon I, Kim YH, Cho J.
Longterm extracorporeal membrane oxygenation after
severe blunt traumatic lung injury in a child. Acute
Crit Care 2017 Feb 10 [Epub]. https://doi.org/10.4266/
acc.2016.00472.
Web sites
Sage Terapeutics. A study with SAGE-547 for superrefractory
status epilepticus [Internet]. Bethesda (MD): U.S.
National Library of Medicine; 2000 [cited 2016 Nov 12].
Available from: https://clinicaltrials.gov/ct2/show/NCT02
477618?term=NCT02477618&rank=1.
9. Tables and figures
ACNM publishes in full color and encourages authors to use
color to increase the clarity of figures. An individual should
not be recognizable in photographs or X-ray films provided
at the time of submission. Authors must submit figures and
illustrations as electronic files. Images must be provided as
TIF files or JPEG. Each figure must be of good quality, higher
than 300 dpi resolution with good contrast and sharpness.
Submit files of figures and photographs separately from the
text of the paper. Number figures as “Figure Arabic numeral"
in the order of their citation (ex. Fig. 1). If a figure is divided
into more than two images, mark each figure with Arabic
numerals and a capital letter (ex. Fig. 1A, Fig. 1B). Authors
should submit line drawings in black and white. Figures
should be explained briefly in the titles. Explain all nonstandard
abbreviations in footnotes, and use the following symbols,
in sequence: a, b, c, d, (ex. Rad = radiation; Chemo =
chemotherapy; NS = not significant. *P<0.001). Brief title of
tables and figures should be descript as the verse or phrase
in the above line of tables and the section of figure legends,
respectively. Only the first character of the title should be
capitalized. The first character of each cell in tables is also
capitalized. Figure legends must describe all abbreviations
and acronyms used in the figure. This section should be
typed on a separate page.
Case reports
The manuscripts for case reports should be organized in the
following order: Introduction, Case report, Conclusion, Author
contributions, Conflicts of interest, Acknowledgments,
Orcid, and References.
Case reports describe unique and instructive cases that make
an important teaching point or scientific observation, novel
techniques, use of new equipment, or new information on
diseases that are of importance to the clinical nutrition and
metabolism. The length from introduction to conclusion
should not exceed 1,500 words. The abstract should be one
paragraph less than 200 words. The maximum number of
references is 20, 6 for figures and 5 for tables.
Review articles
Review articles are usually requested by the Editor in Chief.
However, unrequested reviews could be considered after contacting
the Editor in Chief by e-mail to determine the appropriateness
of the review to ACNM. The main text consists of
the Introduction, Main body, and Conclusion sections. The
number of references should be limited to 80. Otherwise, it
ACNM ANNALS OF CLINICAL NUTRITION AND METABOLISM
keeps the style and format of original articles but the details
may be more flexible depending on the contents.
Editorials
Editorials provide invited perspective on an area of clinical
nutrition and metabolism, dealing with very active fields of
research, current interests, fresh insights and debates. An abstract
is not required and a brief unstructured text should be
prepared. Although editorials are normally invited or written
by an Editor, unsolicited editorials may be submitted. The
length should not exceed 1,000 words and 10 references.
Letter to the editor
Letters to the Editor should include brief constructive comments
that concern a published article; a short, freestanding
opinion; or a short, interesting case. Letters to the Editor
should be submitted no more than 1 year after the relevant
paper has been published. Body text should not exceed 1,000
words and should have less than 10 references. Responses
from the author of the relevant paper may be provided. The
responses should have the same format of Letters to Editor.
PEER REVIEW PROCESS
The decision on the acceptance of unsolicited manuscripts
is based on the results of a peer review by two or more experts
in the corresponding field. To ensure unbiased review,
reviewers receive manuscripts without the authors’ names.
When the editorial board requests revisions, authors should
complete the revision within 4 weeks or else it will be considered
as withdrawn by the author. The Editorial Board will
make the final decision on approval for the publication of
submitted manuscripts and the publication order of accepted
manuscripts. The Editorial Board considers ethics, rationality,
originality, and scientific significance in accepting submitted
manuscripts, and can request further corrections, revisions,
and deletions of articles, if necessary. ACNM follows the
Recommendations for the Conduct, Reporting, Editing, and
Publication of Scholarly Work in Medical Journals available
at: http://www.icmje.org/, if otherwise not described below.
The Editorial Board may request authors to correct English
to reach a certain standard and authors should accept the
request. The Editorial Board will make a final decision on the
approval of the submitted manuscript for publication and
can request any further corrections, revisions, and deletions
of the article text if necessary. Statistical editing is also performed
if the data requires professional statistical review by
a statistician.
PUBLICATION PROCESS
Fee for publication and reprints
There is no article processing charge to author. However, this
policy could be changed in the future.
If an article is accepted for publication, the corresponding
author will receive the proof and typeset for the publication.
Please note that the author is responsible for all statements
made in their work, including changes made during the editorial
process – authors should check proofs carefully.
EDITORIAL POLICY
The Editorial Board will continuously work to monitor and
safeguard publication ethics: guidelines for retracting articles;
maintenance of the integrity of the academic record;
preclusion of business needs from compromising intellectual
and ethical standards; publishing corrections, clarifications,
retractions, and apologies when needed; and excluding plagiarism
and fraudulent data. The editors maintain the following
responsibilities: responsibility and authority to reject
and accept articles; avoiding any conflict of interest with
respect to articles they reject or accept; promoting publication
of corrections or retractions when errors are found; and
preservation of the anonymity of reviewers.
The editor assumes that all authors listed in a manuscript
have agreed with the following policy of ACNM on submission
of manuscript. Except for the negotiated secondary
publication, manuscript submitted to the journal must be
previously unpublished and not be under consideration for
publication elsewhere. Under any circumstance, the identities
of the referees will not be revealed. If a new author should
be added or an author should be deleted after the submission,
it is the responsibility of the corresponding author to
ensure that all of the authors concerned are aware of and
agree to the change in authorship. All published manuscripts
become the permanent property of the ACNM and must not
be published elsewhere without written permission.
Secondary publication
It is possible to republish manuscripts if the manuscripts
satisfy the conditions of secondary publication of the ICMJE
Recommendations (http://www.icmje.org/urm_main.html).
Similarity check
Similarity Check is a multi-publisher initiative to screen
published and submitted content for originality. To find out
more about Similarity Check, visit http://www.crossref.org/
crosscheck.html. All manuscripts submitted to ACNM may be
screened, using the iThenticate tool, for textual similarity to
other previously published works.
Publication process after acceptance
If an article is accepted for publication, the corresponding
author will receive the proof and typeset for the publication.
Please note that the author is responsible for all statements
made in their work, including changes made during the editorial
process – authors should check proofs carefully. ACNM
recommends authors to keep the corrections to a minimum.
Note that proofs should be returned within 48 hours from
receipt of the first proof.
Manuscripts for submission to
Surgical Metabolism and Nutrition should be prepared according to the following instructions.
Surgical Metabolism and Nutrition follows the Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication [1].
1. General Consideration
A. Language
Manuscripts must be written in Korean, but manuscripts in English are possible following revising by a professional linguistic reviewer.
B. Manuscript Categories
Surgical Metabolism and Nutrition publishes original articles, case reports, review articles, editorials, and letters to the editors.
- Original articles: original articles are full-length reports on basic and clinical investigation of nutritional and metabolic support for peri-operative patients.
- Case reports: only cases that are reported for the first time or collections of rare cases are qualified for review.
- Review articles: review articles are usually requested by the Editor in Chief. However, unrequested reviews could be considered after contacting the Editor in Chief by e-mail (cmcgslee@catholic.ac.kr) to determine the appropriateness of the review to Surgical Metabolism and Nutrition.
- Editorials: editorials are invited articles written as a companion to an article for publication.
- Letter to the editor: brief reports related to articles published in Surgical Metabolism and Nutrition. The editor can forward the Letter to the corresponding author of the article for discussion. The corresponding author can report the refutation of Letter as “Author reply”.
C. Peer review and publication process
All submitted manuscripts are subject to editorial peer review. After peer review, acceptance for publication and order are decided by the editorial board. If authors are asked to revise the manuscript, authors should re-submit the revised manuscripts and response to revision within a suggested period of time. Unless the author keeps the limited period for revision of the manuscript, the re-submitted article should be regarded as the initial submission.
D. After acceptance
Editor will send the author’s page proof, and authors are permitted to correct inappropriate phrases and grammar, except for content of the text. After corrections, authors should finally submit manuscripts within a limited period of time.
E. Copyright
On acceptance, all authors should transfer copyright of their article to
Surgical Metabolism and Nutrition. Accepted articles are the permanent property of
Surgical Metabolism and Nutrition, and the commercial use of articles without written consent of the publisher is prohibited.
2. Online Submission Process
All manuscripts for
Surgical Metabolism and Nutrition must be submitted through the KSSMN Submission System website (www.smn.or.kr/submission). Authors have to log into their account in the on-line system, which will lead the authors through the submission process. To start the submission process, select “New Manuscript”.
3. Manuscript Preparation Guideline
A. Contents and Consideration
- Manuscripts must be submitted as MS-WORD (2003 or higher) files using a normal, plain format (e.g., 10 point, Time Roman or Arial for English, 명조체 or 고딕체 for Korean). Manuscripts must be double-spaced with wide margins throughout and divided as follows: 1) Title Page, 2) Structured Abstract, 3) Text, 4) Acknowledgement, 5) References, 6) Tables, and 7) Figure Legends. Each section should begin on a separate sheet and follow in that order.
- In Korean articles, academic words recommended by the “Medical Dictionary” published by the Korean Medical Association in 2001 should be used. Medical terms without suitable translated words, proper noun, place name, anthroponym, or unit could be presented in English.
- Terms that are presented frequently may be abbreviated in English. Abbreviations must be used consistently and defined on first use.
- Arabic numbers should be used, and all units use SI unit (International Systemic of Units). Use a comma after thousands (ex: 10,000).
- Regarding devices, reagents, and medicine, information on manufacturing company, city, and nation should be provided in parenthesis.
B. Title Page
- Title page is comprised of 1) Article title, 2) Authors’ name, 3) Authors’ affiliation, 4) Corresponding author, and 5) Source of financial and material support or Presentation at an official scientific meeting.
- Article title is concrete and contents of the study are implicated. Titles such as “study about” should be avoided, and a title that is too short may lack important information, such as design (which is particularly important in identification of randomized, controlled trials).
- Authors’ name and affiliations should be provided. When affiliations of authors are different, those should be discriminated in front of affiliation and behind the author’s name as superscripts of Arabic numerals without parenthesis.
- Designate a corresponding author and include a complete mailing address, telephone number, fax number, and e-mail address. Specify the address to which requests for reprints should be sent.
- If the manuscript was presented at an official scientific meeting, specify the name of the meeting and the city where it was held.
- All sources of financial and material support should be presented at the bottom of the title page.
C. Abstract
- Title, authors, affiliation of authors, and abstract are listed.
- In original and review articles, the abstract should not exceed 250 words. Original articles should be arranged with the following subheadings: Purpose, Materials and Methods, Results, Conclusions.
- Abstract of case reports is limited to no more than 150 words. Editorial and Letter to editorial do not require the abstract.
iv. Do not use abbreviations in the abstract.
- Up to five keywords should be listed at the bottom of the abstract. These words should be drawn from the Medical Subject Heading (MeSH) terminology in the United States National Library of Medicine’s (NLM) MEDLINE database [2]. The first letter of the keyword should be capitalized and the remaining letters should be lower case; they should be separated by a comma, with a period at the end of the last word.
D. Text
- Original Article
The main text of the original article should include Introduction, Methods, Results, and Discussion sections. Introduction should provide a brief background and aims of the study. Methods should clearly provide your selection of the observational or experimental participants, including eligibility and exclusion criteria and a description of the source population in the case of clinical research. In addition, give statistical methods and provide references and brief descriptions for methods that have been published. Give reasons for using new or modified methods.
Methods of clinical trial should be presented with the approval of the institutional review board (IRB) and informed consents from patients enrolled in that trial.Results are listed according to the order of figures and tables presenting the results of study. Do not repeat all data in the figures or tables in the text of the results section and emphasize the important results briefly.
Discussion should be limited to important aspects of the study and the conclusions that follow from them. Do not repeat in detail data or previously given information in the Results section. Avoid content unrelated to the results.
- Case Report
Case report should be divided into Introduction, Case report, and Discussion. The number of figures or illustrations should not exceed 5.
- Review
Introduction, main body, and conclusions should be listed.
- Citation of reference in text
References should be numbered consecutively in the order in which they are first mentioned in the text. Identify references in text, tables, and legends by Arabic numerals in parenthesis.
E. Acknowledgement
List all persons who have made substantial contributions to the work reported in this manuscript, but who are not authors.
F. References
References should be numbered consecutively in the order in which they are first mentioned in the text. All international or domestic references should be listed in English and should be represented in Vancouver style. The abbreviated journal title should be written according to the
List of Journals Indexed for MEDLINE [3] and the
List of KoreaMed Journals [4]. The number of references should be limited to 30 in original articles, 40 in review articles, and 15 in case reports.
References to books or journals with six or fewer coauthors must list all authors. References with seven or more authors should list only the first six followed by “et al.” Names should be separated by a comma and one space. References should follow the rules of the
International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals [1].
References to manuscripts accepted but not published at the time of submission should be designated as “In press.”
References to manuscripts accepted but only electronically published at the time of submission should be designated as “In print”.
References to websites should be limited to official government websites.
Personal communications or unpublished data must be cited within the text and not in the references and should use the following format: “(Name, personal communication)” or “(Name, unpublished data).”
For reference material not described here, follow the NLM Style Guide for Authors, Editors, and Publishers [5].
< Examples >
Journal
Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE. Longterm results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal cancer. Int J Radiat Oncol Biol Phys 1991;20:29-36.
Book
DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Vol 2. 4th ed. Philadelphia: Lippincott, 1998.
Chapter in Book
Ginberg RJ, Kris MG, Armstrong JG. Cancer of the lung. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Vol 2. 4th ed. Philadelphia: Lippincott, 1993:673-758.
Website
http://www.nso.go.kr/Accessed November 18, 2004
G. Tables and Figures
- Tables and figures are numbered in the order of text. Each table and figure is cited in the text in English and Arabic numerals.
Ex) −있다 (Table 1). −이다 (Fig. 1). Table 2는 −.
- Tables and figures should capture information from the text concisely and display it efficiently. In addition, they should provide information of detail and precision.
- Brief title of tables and figures should be descript as the verse or phrase in the above line of tables and the section of figure legends, respectively. Only the first character of the title should be capitalized. The first character of each cell in tables is also capitalized.
- Figure legends must describe all abbreviations and acronyms used in the figure. This section should be typed on a separate page.
- Explain all nonstandard abbreviations in footnotes, and use the following symbols, in sequence: *, †, ‡, §, ∥, ¶, **.
Ex) Rad = radiation; Chemo = chemotherapy; NS = not significant. *P<0.001.
- Upload each illustration as a separate file in a specific format (for example: JPEG or TIF). Compounding figures (1A, 1B,−) should be supplied as a single file. Line drawings are acceptable as clear black on white graphics and must be high quality. All figures must be supplied at the correct resolution. 1200 dpi for black and white line art 600 dpi for black and white photograph 300 dpi for color photograph.
- Written permission should be obtained for use of all previously published materials and authors should provide a full acknowledgement in the figure legend.
- For photomicrograph, indicate the staining method and a measure of magnification in figure legends.
Ex) H & E stain, ×400
- Each table should be described on a separate sheet of paper.
4. Ethical Issues
A. Conflict of interest statement
If there are any conflicts of interest, authors should disclose them in the manuscript.
B. Statement of informed consent
Copies of written informed consent and IRB approval for clinical research should be maintained. If necessary, the editor or reviewers may request copies of these documents in order to resolve questions about IRB approval and study conduct.
C. Statement of human and animal rights
Clinical research should be conducted in accordance with the Ethical Principles for Medical Research Involving Human Subjects, as outlined in
The Declaration of Helsinki [6]. Clinical studies that do not meet the Helsinki requirements will not be considered for publication. Human subjects should not be identifiable; patients’ names, initials, hospital numbers, dates of birth, or other protected healthcare information should not be disclosed. For animal subjects, research should be conducted based on the National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals should be maintained.
D. Authorship
Authorship of the manuscript submitted in
Surgical Metabolism and Nutrition should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically; or 3) final approval of the version to be published. Authors must meet at least one of these three conditions.
E. Originality and duplicate publication
All submitted manuscripts should be original and should not be under consideration for publication by other scientific journals at the same time. No part of the accepted manuscript should be duplicated in any other scientific journal without the permission of the Editorial Board of
Surgical Metabolism and Nutrition. If duplicate publication related to materials in this journal is detected, the authors will be held responsible and their institutions will be informed; there will also be penalties for the authors.
Abstracts and posters from scientific conferences and results presented at meetings are not considered as prior publication.
F. Secondary publication
It is possible to republish manuscripts if the manuscripts satisfy the condition of secondary publication of the
Uniform Requirements for Manuscripts Submitted to Biomedical Journals [1].
5. References
- International Committee of Medical Journal Editor: Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication [Internet]. International Committee of Medical Journal Editor; 1979 [Updated 2008 Oct; cited 2009 Aug 1]. Available from: http://www.icmje.rg/.
- National Library of Medicine (US): MeSH [Internet]. Bethesda (MD): National Library of Medicine (US); 1954 [updated 2009, cited 2009 Aug 1]. Available from: http://www.ncbi.nlm.nih.gov/sites/entrez?db= mesh.
- National Library of Medicine (US): Journals [Internet]. Bethesda (MD): National Library of Medicine (US); 2009 [cited 2009 Aug 1]. Available from: http:// www.ncbi.nlm.nih.gov/sites/entrez?db=journals.
- Korean Association of Medical Journal Editors: KoreaMed: List of Journals [Internet]. Seoul (Korea): Korean Association of Medical Journal Editors; 1997 [updated 2009, cited 2009 Aug 1]. Available from: http://www.koreamed.org/JournalBrowser.php.
- National Library of Medicine (US): Journals [Internet]. Bethesda (MD): National Library of Medicine (US); 2009 [cited 2009 Aug 1]. Available from: http:// www.ncbi.nlm.nih.gov/sites/entrez?db=journals.
- World Medical Association: Declaration of Helsinki [Internet]. Ferney-Voltaire (France): World Medical Association; 1964 [updated 2008 Oct; cited 2009 Aug 1]. Available from: http:// http://www.wma.net/e/ policy/b3.htm.